Author

Mary Rose Stang

Observed names: M R Stang, M Stang, Stang, Mary Rose

Institutions: Saskatchewan Health, University of Saskatchewan, Government of Saskatchewan

Observed institutions: Pfizer (United States), Saskatchewan Health, University of Saskatchewan, Government of Saskatchewan, Degge Group (United States)

OpenAlex ID: A5111980005

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

2005 · Suellen M. Curkendall, Cynthia deLuise, et al. · Annals of Epidemiology · 620

Incidence of lactic acidosis in metformin users.

1999 · M Stang, D K Wysowski, et al. · Diabetes Care · 325

Cardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada

2004 · Suellen M. Curkendall, Jingping Mo, et al. · The Journal of Clinical Psychiatry · 201

Use of antidepressants and risk of colorectal cancer: a nested case-control study

2006 · Wanning Xu, Hani Tamim, et al. · The Lancet Oncology · 143

Health Databases in Saskatchewan

2000 · Winanne Downey, Patricia Beck, et al. · Pharmacoepidemiology · 124

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

2005 · David F Blackburn, Roy T Dobson, et al. · PubMed · 122

Chronic obstructive pulmonary disease severity and cardiovascular outcomes

2006 · Suellen M. Curkendall, Stephan Lanes, et al. · European Journal of Epidemiology · 120

Positive predictive value of ICD‐9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database

2008 · Cristina Varas‐Lorenzo, Jordi Castellsague, et al. · Pharmacoepidemiology and Drug Safety · 109

Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis

2013 · Ying Jiang, Nathaniel Osgood, et al. · Canadian Medical Association Journal · 52

PDF

The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

2009 · Cristina Varas‐Lorenzo, Jordi Castellsague, et al. · Pharmacoepidemiology and Drug Safety · 38

The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases

2008 · Luis Alberto García‐Rodríguez, Antonio González‐Pérez, et al. · Pharmacoepidemiology and Drug Safety · 34

PDF

The Relationship Between Diabetes and Tuberculosis in Saskatchewan

2007 · Roland F. Dyck, Helena Klomp, et al. · Canadian Journal of Public Health · 30

PDF

Antidepressants and risk of prostate cancer: a nested case – control study

2007 · H M Tamim, S Mahmud, et al. · Prostate Cancer and Prostatic Diseases · 25

An Association of Maternal Age and Birth Weight with End-Stage Renal Disease in Saskatchewan. Sub-Analysis of Registered Indians and Those with Diabetes

2003 · Roland Dyck, Helena Klomp, et al. · American Journal of Nephrology · 24

End Stage Renal Disease Among People with Diabetes: A Comparison of First Nations People and Other Saskatchewan Residents from 1981 to 2005

2010 · Roland F. Dyck, Nathaniel D. Osgood, et al. · Canadian Journal of Diabetes · 20

The Epidemiology of Diabetes Mellitus among First Nations and non-First Nations Children in Saskatchewan

2012 · Roland Dyck, Nathaniel Osgood, et al. · Canadian Journal of Diabetes · 17

PDF

Coding of heart failure diagnoses in Saskatchewan: a validation study of hospital discharge abstracts.

2011 · David F Blackburn, Greg Shnell, et al. · PubMed · 5

Contents Vol. 23, 2003

2003 · Krzysztof Okon, Anna Szumera, et al. · American Journal of Nephrology

Works count: 19

Citation count: 2,009

H-index: 16

I10-index: 16